The global Humira market is carefully researched in the report while largely concentrating on top players and their business tactics geographical expansion market segments competitive landscape manufacturing and pricing and cost structures. Each section of the research study is specially prepared to explore key aspects of the global Humira market. For instance the market dynamics section digs deep into the drivers restraints trends and opportunities of the global Humira Market. With qualitative and quantitative analysis we help you with thorough and comprehensive research on the global Humira market. We have also focused on SWOT PESTLE and Porter’s Five Forces analyses of the global Humira market.
Leading players of the global Humira market are analyzed taking into account their market share recent developments new product launches partnerships mergers or acquisitions and markets served. We also provide an exhaustive analysis of their product portfolios to explore the products and applications they concentrate on when operating in the global Humira market. Furthermore the report offers two separate market forecasts – one for the production side and another for the consumption side of the global Humira market. It also provides useful recommendations for new as well as established players of the global Humira market.
Get a PDF template of this report: https://www.qyresearch.in/request-sample/pharma-healthcare-humira-global-comprehensive-analysis-of-industry-dynamics-and-market-sales-trends-2024
Humira (adalimumab) is a tumor necrosis factor (TNF) blocker that reduces the effects of a substance in the body that can cause inflammation.
Humira is used to treat many inflammatory conditions in adults such as ulcerative colitis Rheumatoid Arthritis psoriatic arthritis Ankylosing Spondylitis plaque psoriasis and a skin condition called hidradenitis suppurativa.
Humira is also used in adults and children to treat Crohn’s disease or juvenile idiopathic arthritis.
In 2014 in India the first adalimumab biosimilar came to market at a price of $200. Two years later another Indian drugmaker Torrent Pharmaceuticals launched a second biosimilar. Humira’s U.S. patent expired in 2016.
The global Humira market size is expected to reach US$ 9235.6 million by 2029 growing at a CAGR of -8.3% from 2023 to 2029. The market is mainly driven by the significant applications of Humira in various end use industries. The expanding demands from the Ankylosing Spondylitis Rheumatoid Arthritis Crohn’s Disease and Others are propelling Humira market. Humira Syringe one of the segments analysed in this report is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Humira Pen segment is estimated at % CAGR for the next seven-year period.
The classification of Humira includes Humira Syringe and Humira Pen. The proportion of Humira Syringe is about 78%.
Humira is widely used for Ankylosing Spondylitis Rheumatoid Arthritis Crohn’s disease and other disease. The most proportion of Humira is for Ankylosing Spondylitis and the proportion is about 43%.
USA is the largest market with a sales market share nearly 65%. Following USA Europe is the second largest market with the sales market share of 30%.
Market competition will intense. AbbVie Eisai Cadila Healthcare Torrent Pharmaceuticals Amgen and Boehringer Ingelheim are the key manufacturters of Humira. AbbVie is the leader of this industry by 97% market shares.
Report Objectives
This report provides market insight on the different segments by manufacturers by Type by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts growth rates market dynamics industry structure and developments market situation trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Humira with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Humira market and provides market size (US$ million) and CAGR for the forecast period (2023-2029) considering 2022 as the base year.
This report profiles key players in the global Humira market based on the following parameters – company details (found date headquarters manufacturing bases) products portfolio Humira sales data market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers restraints opportunities market trends regional outlook.
Key companies of Humira covered in this report include AbbVie Eisai Cadila Healthcare Torrent Pharmaceuticals Amgen and Boehringer Ingelheim etc.
The global Humira market report caters to various stakeholders in this industry including investors suppliers product manufacturers distributors new entrants and financial analysts.
Market Segmentation
Company Profiles:
AbbVie
Eisai
Cadila Healthcare
Torrent Pharmaceuticals
Amgen
Boehringer Ingelheim
Global Humira market by region:
North America (U.S. Canada Mexico)
Europe (Germany France UK Italy etc.)
Asia Pacific (China Japan South Korea Southeast Asia India etc.)
South America (Brazil etc.)
Middle East and Africa (Turkey GCC Countries Africa etc.)
Global Humira market Segment by Type:
Humira Syringe
Humira Pen
Global Humira market by Application
Ankylosing Spondylitis
Rheumatoid Arthritis
Crohn’s Disease
Others
Core Chapters
Chapter One: Introduces the study scope of this report executive summary of market segments by Type market size segments for North America Europe Asia Pacific South America Middle East & Africa.
Chapter Two: Detailed analysis of Humira manufacturers competitive landscape price sales revenue market share and ranking latest development plan merger and acquisition information etc.
Chapter Three: Sales revenue of Humira in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects and market space in the world.
Chapter Four: Introduces market segments by Application market size segment for North America Europe Asia Pacific South America Middle East & Africa.
Chapter Five Six Seven Eight and Nine: North America Europe Asia Pacific South America Middle East & Africa sales and revenue by country.
Chapter Ten: Provides profiles of key players introducing the basic situation of the main companies in the market in detail including product sales revenue price gross margin product introduction recent development etc.
Chapter Eleven: Analysis of industrial chain key raw materials manufacturing cost and market dynamics. Introduces the market dynamics latest developments of the market the driving factors and restrictive factors of the market the challenges and risks faced by manufacturers in the industry and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
for Pre-Order Inquiry: https://www.qyresearch.in/pre-order-inquiry/pharma-healthcare-humira-global-comprehensive-analysis-of-industry-dynamics-and-market-sales-trends-2024
About Us:
QYResearch always pursuits high product quality with the belief that quality is the soul of business. Through years of effort and supports from the huge number of customer supports QYResearch consulting group has accumulated creative design methods on many high-quality markets investigation and research team with rich experience. Today QYResearch has become a brand of quality assurance in the consulting industry.